NUCLEIC ACID INTERACTING UNFUSED HETEROPOLYCYCLIC COMPOUNDS

摘要

The compounds of the present invention are derivatized unfused heteropolycyclic compounds, primarily heterotricyclic compounds, formed by replacing the halogen atoms adjacent to diazine ring nitrogens or the benzylic halogenin 2,6-bis[4-(bromomethyl)phenyl]pyridine with one of a variety of common nucleophiles such as the hydroxide ion, alkoxides, mercaptides, and amines. These compounds interact with nucleic acids, thereby inhibiting translation and interfering with viral replication processes, such as the replication of HIV, the virus believed to cause AIDS. The preferred compounds at this time are 2,6-bis[4'-[(dimethylamino)methyl]phenyl]pyridine (DH-23); 4,6-bis[4'-[[2''-(dimethylamino)ethyl]thio]phenyl]-5-methylpyrimidine (LS-22); N-[2''-(dimethylamino)ethyl]-4-(benzo[b]thiophen-2'-yl)quinazolin-2-amine (M-116); N,N-bis(2''''-hydroxyethyl)-2-[[4'-(benzo[b]thiopen-2''-yl)-6'-(thien- 2'''-yl)pyrimidin-2'-yl]oxy]ethylamine (DH-42); bis-4,6-[4'-[[2''-(dimethylamino)ethyl]thio]phenyl]pyrimidine (LS-20); 1-methyl-4-[2'-[[4''-(naphth-2'''-yl) quinazolin-2''-yl]thio]ethyl]piperazine (M-69); N,N-bis-(2'-hydroxyethyl)-4,6-bis(thien-2''-yl)pyrimidin-2-amine (M-103); N,N-bis(2'-hydroxyethyl)-2-[[4'',6''-bis(thien-2'''-yl)pyrimidine-2''y l]oxy]ethylamine (M-105); and 4-[3'-[[2''-(dimethylamino)ethyl]thio]phenyl]-2-[[2'''-(dimethylamino) ethyl]thio] pyrimidine (DH-19). Advantages of these compounds include low cost and ease of manufacture.